When considering the causes of blindness, it is impossible to ignore the importance of glaucoma. Although several studies have elucidated the genetic mutations resulting in some forms of glaucoma (summarized at
http://neibank.nei.nih.gov/cgi-bin/CDL/showDiseaseLoci.cgi?dt=Glaucoma), most of these studies have considered individual genes rather than associated networks of coregulated genes. The systematic genetics approach has proven to be a powerful tool for identifying candidate genes and for the construction of genetic networks that regulate nervous system function.
24 We combined this successful methodology with our powerful genetic resource of RI strains of mice to reveal the network of genes that covary with
Gpnmb, a gene that contributes to PDS and PG in the D2 mouse.
In our study, we excluded the BXD24 strain from all analyses given that the Cep290 mutation in its genome has a very strong effect on the relative expression levels of all transcripts in the eye. This is because the Cep290 mutation causes a total loss of photoreceptors before 2 months of age, thus distorting the normalization of all transcript levels in the eye. In contrast, strains with mutations in Gpnmb maintain their entire complement of ocular cells, and, therefore, the normalization of transcript levels is not grossly distorted. In fact, the slight variations in relative transcript levels between BXD strains with wild-type versus mutant Gpnmb allowed us to determine with great sensitivity other transcripts whose levels are modulated by the presence of the R150X mutation in Gpnmb.
The
Gpnmb gene is predicted to encode a transmembrane protein with homology to the melanosomal protein silver (
Si). The GPNMB protein encoded by this gene is an intracellular, endosomal/melanosomal protein that is predicted to be important for the biosynthesis of melanin and the development of the retinal pigment epithelium and the iris, the pigmented tissues within the eye.
13 It is also expressed by low-metastasizing melanoma cells.
10 Although this knowledge is certainly useful, the focus is narrow and may overlook coregulated genes that are altered by SNPs or mutations in
Gpnmb. Our study sought to expand on this functional knowledge by identifying loci that regulate
Gpnmb expression and other genes whose expression levels covary with
Gpnmb. Because previous investigations have suggested that
Gpnmb plays a significant role in the immune response in the eye, specifically anterior chamber-associated immune deviation,
15 one of our goals was to determine whether
Gpnmb participated in immunomodulatory pathways in the eye. In this investigation, we were unable to identify any link between
Gpnmb expression levels and the regulation of immune responses. However, this finding does not rule out a biological interaction at the protein level.
In our expression analysis, the abundance of a transcript was treated as a quantitative trait, allowing us to perform conventional linkage analysis to find the genetic loci that affect transcript abundance. However, transcript levels for a given gene differ from traditional phenotypes in that each transcript has a corresponding encoding gene with a known position in the genome. As mapping studies reveal the location of QTLs, their expression can be classified as cis (acting within 3 Mb of the location of the gene itself) or trans (acting elsewhere in the genome). Our investigation revealed a very large cis-eQTL (LRS score of 110.7) that regulates the expression level of Gpnmb. Comparison of this score with those of all 45,101 probes on the Affymetrix chip (M430V2) revealed that only 427 probes have cis-eQTLs of 110.7 or greater. This places the cis-eQTL in the upper 0.95% of cis-eQTLs in the mouse genome.
Binding of a transcription factor to the promoter region of a gene is traditionally regarded as the main mechanism by which gene expression is regulated. Recent studies
32,33 have shown, however, that polymorphisms within both intronic and exonic regions also play an important role in regulating gene expression. In our study, we found multiple SNPs in the 3′-UTR, intronic, and exonic regions of the
Gpnmb gene (
Supplementary Appendix S7). One of the SNPs encoded for the stop codon in exon 4, previously reported by Anderson et al.
34 The SNP at 48.995384 Mb has been previously documented to introduce a stop codon that encodes for a truncated protein of 150 amino acids, which is less than half the full-length protein. It was predicted that the mutant mRNA undergoes nonsense-mediated decay
34 and the transcript is not translated into protein, thus making it a loss-of-function mutation. Our RNASeq data demonstrate that the D2 mouse has very low levels of expression across the entire transcript, which supports the hypothesis that the
GpnmbR150X mutant transcript is degraded and not expressed. Our Western blot data further corroborate this prediction and demonstrate that in BXD lines with low transcript levels of
Gpnmb, no GPNMB protein is expressed, similar to what was documented in the D2 parental strain.
15
To reveal the possible mechanisms by which Gpnmb functions in the eye, we stratified the RI lines based on the presence or absence of the GpnmbR150X mutation and performed analyses on each data set separately. Importantly, control of the expression levels of genetic correlates was heritable for strains with both wild-type and mutant alleles. Interestingly, there was no overlap of biological process categories in the GO enrichment graphs generated from transcripts correlated with wild-type or mutant Gpnmb. Furthermore, there was no overlap in any of the chromosomal regions in which Gpnmb correlates are localized, as shown by the heat maps. These data demonstrate that the loss-of-function mutation dissociates Gpnmb from its normal biological functions and molecular networks, which may result in abnormal interactions at both the transcriptional and the protein levels.
Given its localization in pigmented tissues,
13,15 it was not unexpected that wild-type
Gpnmb correlated with other genes (i.e.,
Dct and
Si) involved in melanin synthesis. Our finding is supported by a recent paper demonstrating, with a melanocyte cell line and traditional microarray analysis, that
Gpnmb is coregulated with
Dct and
Si.
35 Other categories with which
Gpnmb also correlated in our study included genes involved in cell motility and migration. This finding is supported by a recent publication in which an association between
Gpnmb and cell adhesion, a component of migration, was documented.
36 Collectively, these data indicate that our systematic genetics approach is powerful in predicting physiological functions of a gene based on other transcripts similarly regulated at the mRNA level.
Novel biological process categories represented in the GO enrichment analysis from the mutant
Gpnmb data set are involved in posttranslational modifications and stress activated signaling, each of which includes kinases such as tyrosine protein kinase, serine/threonine kinase, receptor-associated kinase, and guanine nucleotide exchange. Another enriched category of the mutant
Gpnmb correlate graph relates to visual perception. Seven of the eight genes in this category were positively correlated with
Gpnmb expression, which meant these seven genes were downregulated in the mutant. Four of the downregulated gene products—
Kcnv2, Opn1sw, Rho, and
Cnga1—function as part of the phototransduction cascade, whereas the other three—
Rom1, Opn1sw, and
Rho—function as structural proteins. Several very careful studies in the D2 mouse have demonstrated age-related changes in visual acuity, visual function, and photoreceptor morphology, including inner and outer segment length and number of cells in the outer nuclear layer,
37,38 though the structure of the outer segment is not compromised.
39 Although ROM1 is a structural protein, elegant studies have demonstrated that this protein is involved in determining the fine structure of the outer segment as opposed to its binding partner, RDS/peripherin, which mediates folding of the outer segment membranous discs.
40 Our data lend support for these functional and anatomic studies of the outer retina in the D2 mouse. They also further document the sensitivity of a systematic genetics approach; we are able to predict structural and functional abnormalities in D2 mice before they become manifest.
Comparison of the outcomes of our present investigation with those of other investigators using microarray analysis of gene expression and mutations in
Gpnmb and
Tyrp1 yielded differences among all studies. For example, using iris samples taken from B6.
Tyrp1b GpnmbR150X B6 mice, Anderson et al.
41 identified an overexpression of several transcripts, including several crystallins (
Gja3 and
B3gnt5) compared with B6 mice. In contrast, Vetter et al.
42 found an upregulation of transcripts involved in the immune response along with a downregulation of crystallins in retinas from D2 mice at an advanced age. All differences can be readily explained in light of the differences in tissues used in each study and the genetic backgrounds of the mice. Nonetheless, each study provides valuable information.
Given that mutations in both Gpnmb and Tyrp1 contribute to the glaucoma phenotype of D2 mice, it was unexpected that the expression level of Tyrp1 did not correlate with the expression level of mutant Gpnmb. Our unpublished data demonstrate that in BXD strains, the iris transillumination defect maps to Tyrp1 as early as 1 to 2 months. In contrast, the defect does not map to Gpnmb until mice are older than 13 months old. These data collectively suggest that although mutations in both genes increase the severity of the iris defect in PDS, they are differentially regulated and function within distinct pathways in the eye.
To verify the ability of GeneNetwork to identify interactions of a gene of interest with the immune system, if such an interaction took place, we performed identical correlation analysis with Cd53, a gene expressed by T cells and natural killer cells. In RI lines with both wild-type and mutant Gpnmb, Cd53 was highly correlated with many members of various immunologic biological functions. The biological function categories enriched for the immune system included regulation of immune system processing, activation of immune response, regulation of acute inflammatory response to antigenic stimulus, and regulation of type I hypersensitivity. Moreover, the strength of the correlations was very high.
In summary, our study demonstrates that Gpnmb is regulated by a very large cis-eQTL and that SNPs within Gpnmb itself, or another gene located very near Gpnmb on chromosome 6, are responsible for the modulation of its expression and that the truncated transcript attributed to the R150X mutation is not expressed at a significant level and likely undergoes nonsense-mediated decay. Genetic correlates of wild-type Gpnmb are involved in melanin synthesis and cell migration; supportive evidence of both functions is found in the literature. The R150X mutation disrupts the functional networks with which Gpnmb is normally associated. The new networks include stress activation, phosphorylation, and visual perception. Within a complex tissue such as the eye or the retina, neither wild-type nor mutant Gpnmb is highly correlated with genetic networks involved with the immune response. It is possible that an enriched population of ocular dendritic cells or antigen-presenting cells is required to reveal this connection.